Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB0500035	TMC 278	rilpivirine	Active ingredient	Chemical Drugs	Supplementary Application	2005-10-21	Tibotec Pharmaceuticals Limited	Tibotec Pharmaceutical Co Ltd;Johnson & Johnson Innovative Medicine	Certificate Issued	2006-12-08	view
JXHB0500034	TMC 278	rilpivirine	Active ingredient	Chemical Drugs	Supplementary Application	2005-10-21	Tibotec Pharmaceuticals Limited	Tibotec Pharmaceutical Co Ltd;Johnson & Johnson Innovative Medicine	Certificate Issued	2006-12-08	view
JXHB0500036	TMC 278	rilpivirine	Active ingredient	Chemical Drugs	Supplementary Application	2005-10-21	Tibotec Pharmaceuticals Limited	Tibotec Pharmaceutical Co Ltd;Johnson & Johnson Innovative Medicine	Certificate Issued	2006-12-08	view
JXHL1000045	TMC435胶囊	simeprevir	Capsule	Chemical Drugs	Import Drug Application	2010-02-21	Tibotec Pharmaceuticals	Tibotec Pharmaceutical Co Ltd	Certificate Issued	2010-08-25	view
JXHL1100030	TMC435胶囊	simeprevir	Capsule	Chemical Drugs	Import Drug Application	2011-02-21	Tibotec Pharmaceuticals	Tibotec Pharmaceutical Co Ltd	Certificate Issued	2012-09-04	view
JXHL1100449	TMC435胶囊	simeprevir	Capsule	Chemical Drugs	Import Drug Application	2011-12-22	Tibotec Pharmaceuticals	Tibotec Pharmaceutical Co Ltd	Certificate Issued	2012-09-12	view